drugset / Trial / NCT01976390

Comparing Everolimus and Sirolimus in Renal Transplant Recipients

NCT01976390

RandomizedParallel-groupOpen-labelPrevention

Summary

This study is being done to compare the effectiveness and safety of two different kidney transplant immunosuppression drugs, Zortress (the study drug) and Rapamune (which is used in the current standard immunosuppression regimen).

Timeline

Start
2013-10-01
Primary completion
2018-07-11
Completion
2019-08-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Everolimus Small molecule 0.75 mg Oral
Comparator Sirolimus Small molecule 3 mg Oral

Indications